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NoWonder No One Trusts Us
I am trying to envision howmy conversationmight go
with apatientwho ismale andolder than50years, now
that the latest draft of the US Preventive Services Task
Force recommendations for prostate cancer screening
hasbeenreleased.1,2While therecommendationsarestill
indraft form, andcouldbe revised, thedraft versionhas
suggested yet another change in the recommenda-
tions for screening. My conversation might go some-
thing like this:
“Mr Jones, let’s talk about prostate cancer
screening.”
MrJones replies, “That’sokay,wetalkedabout it the
last coupleof years, and I finally understand that there’s
noneed to screen forprostate cancer anymore. Screen-
ing leads to more harm than good. I know I didn’t be-
lieve youat first, and it took a lot of convincing, but I get
it now.We don’t need to discuss it again. Let’smove on
to other things.”
Well…,” I reply, “it’s....it’s not exactly like that.”
Nervously,MrJonessays “Did Imisunderstandyou?
Should I have had the PSA test last year?”
“No, not exactly,” I reply, with hesitation. “Wewere
correct not to screen last year…. It’smore that,well, the
recommendations have changed.”
“Huh? The recommendations have changed?
Again?” He looks puzzled. I’m not sure, but I may de-
tect a bit of annoyance on his face. He is a busy execu-
tive, andheusually likesourdiscussions short and to the
point. “Youmean now I should get a PSA?”
“Well,” I reply, ”notexactly.” I’m trying to thinkabout
how to phrase my next comment. “Now we are sup-
posed to discuss the risk and benefit of screening.”
“I thought we already did,” he replies.
“Well, sort of…. I know we went over why the rec-
ommendations had changed, the risk of false positive
and the conclusion of the government panel that there
wasmoreharmthangood inscreening.…”Myvoice trails
off. Something tells me he is not going to like where
this is going. “Well, now, based on additional evidence,
they say we can’t really tell if there is more of a benefit
or more of a harm—it depends on individual values and
preferences.”
As usual, Mr Jones is clear in his response. “I indi-
vidually value and prefer staying healthy.”
“Of course…,” I stammer.
“So which should I do? I come to the doctor to get
recommendations. I’ve heard about this internet site
where theycanorderall yourpreventivehealth labwork
and x-rays online, and they give you links to all the in-
formation that youmayneed. In fact, I read that the an-
nual physical exam is not important anyway,3,4 is that
true?”
“Well, that is what some articles say, but I wouldn’t
say that there is consensus about that.”
“There’s no consensus? Now that’s not surprising,
is it,” he smiles, and shakes his head.
Wehaveknowneachother forover20years. Ipause
and think quietly to myself. I am proud to be part of a
medical systemthat ishonestandtransparentaboutevi-
dence that changes over time. The challenge is how to
explain this tomypatients, tohelp themunderstandthat
they are getting thebest information available, that the
changes are not capricious. How to teach them what I
have learned, that they should alwaysmaintain healthy
skepticism and not believe in things too firmly, but that
evidenceaccumulatesover time, and thereareoften le-
gitimatereasons forchanges in recommendations.Good
medical advicemoves inazigzagpath toward truth, and
thosewho offer it must not pretend to know all the an-
swers. Figuring out how to communicate these parallel
truths is daunting. I see Mr Jones looking toward me,
waiting for my response.
“Well,” I say, “we can talk more about the PSA test
another time. Let’s move on to discuss some issues
around osteoporosis, community-acquired pneumo-
nia, andCdiff, andwhywe should think about stopping
theomeprazole I’vebeenprescribing foryou for thepast
15 years.”5
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